MAXMALA 75MG CAPSULE 10'S

MAXMALA 75MG CAPSULE 10'S is primarily used to treat epilepsy (seizures) and neuropathic pain.

It works by reducing the abnormal activity of nerve cells in the brain, thus helping to control seizures and nerve pain.

Common side effects include dizziness, drowsiness, fatigue, blurred vision, and lack of coordination.

No, MAXMALA 75MG CAPSULE 10'S is not habit-forming, but it should be taken strictly as directed by the doctor.

Store it at room temperature, away from direct sunlight and moisture. Keep out of reach of children.

Drinking alcohol while taking MAXMALA 75MG CAPSULE 10'S can increase side effects like drowsiness and dizziness, so it should be avoided.

If you miss a dose, take it as soon as possible. However, if it is almost time for the next dose, skip the missed dose and continue with your regular schedule.

It is essential to consult a doctor before using MAXMALA 75MG CAPSULE 10'S during pregnancy, as it may harm the unborn baby.

Breastfeeding women should consult a doctor before using MAXMALA 75MG CAPSULE 10'S, as it may pass into breast milk and affect the baby.

People with kidney problems should use MAXMALA 75MG CAPSULE 10'S with caution and consult a doctor, as dosage adjustments may be needed.

People with liver problems should use MAXMALA 75MG CAPSULE 10'S with caution and consult a doctor, as liver function monitoring may be necessary.

MAXMALA 75MG CAPSULE 10'S can interact with certain other medications, so it is important to tell your doctor about all the medications you are taking.

Weight gain can occur in some people taking MAXMALA 75MG CAPSULE 10'S, but it does not happen to everyone.

Symptoms of an overdose of MAXMALA 75MG CAPSULE 10'S may include severe drowsiness, confusion, blurred vision, and lack of coordination.

It may take a few days to a few weeks for MAXMALA 75MG CAPSULE 10'S to start working.

Maxmala 75 is a prescription medicine that typically contains pregabalin 75 mg. It is generally used in adults for the management of neuropathic pain (such as pain due to diabetic neuropathy or post-herpetic neuralgia) and as an adjunctive therapy for certain partial-onset seizures, depending on the prescriber’s assessment and local approvals. In some regions, pregabalin is also used for generalized anxiety disorder. The exact indication for an individual patient should be confirmed with the treating physician.

Pregabalin, the usual active ingredient in Maxmala 75, binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This reduces the release of excitatory neurotransmitters such as glutamate, noradrenaline, and substance P. By dampening abnormal neuronal excitability and neurotransmitter release, it helps reduce neuropathic pain and lowers the likelihood of seizure activity. Its effect develops over days to weeks and is maintained with regular dosing.

Onset of benefit varies between individuals and depends on the condition being treated. Some patients may notice improvement in neuropathic pain within a few days, while others may require 1 to 2 weeks or longer of regular therapy. For seizure control or anxiety, several weeks may be needed to assess full benefit. Treatment response should be reviewed periodically with the prescribing doctor, who may adjust the regimen if needed.

No. The dose and schedule of Maxmala 75 must be determined and adjusted only by a qualified healthcare professional. Factors such as the underlying disease, severity of symptoms, kidney function, age, and other medicines influence the appropriate dose. Self-adjusting the dose, taking more than prescribed, or stopping suddenly can lead to side effects, withdrawal symptoms, or worsening of pain or seizures.

Common side effects of pregabalin-containing medicines like Maxmala 75 include dizziness, drowsiness, blurred vision, weight gain, peripheral edema (swelling of legs or hands), dry mouth, constipation, increased appetite, and difficulty with concentration or coordination. These are often mild to moderate and may improve as treatment continues. However, if side effects are troublesome, persistent, or worsening, medical advice should be sought.

Yes. Although less common, serious adverse effects can occur. These include allergic reactions or angioedema (swelling of the face, lips, tongue, or throat, difficulty breathing), severe skin reactions, new or worsening depression, mood changes, suicidal thoughts or behavior, and severe muscle pain or weakness. Any sudden breathing difficulty, facial or tongue swelling, or marked change in mood or behavior requires immediate medical attention and urgent review of therapy.

Alcohol should generally be avoided or kept to a minimum while taking Maxmala 75. Both alcohol and pregabalin act on the central nervous system and can increase drowsiness, dizziness, impaired coordination, and the risk of falls or accidents. In some individuals, combined use may increase the risk of respiratory depression. Patients should follow their doctor’s specific advice regarding alcohol consumption.

Data on the use of pregabalin during pregnancy are limited, and potential risks to the developing fetus cannot be excluded. Maxmala 75 should only be used in pregnancy if the potential benefit to the mother clearly outweighs the possible risk to the fetus, as judged by the treating physician. Women who are pregnant, planning pregnancy, or who become pregnant while on Maxmala 75 should consult their doctor promptly to review treatment options.

Pregabalin is known to pass into breast milk to some extent. The potential effects on a breastfed infant are not fully established. Use of Maxmala 75 during breastfeeding requires careful risk–benefit assessment by a healthcare professional. In some cases, the doctor may advise avoiding breastfeeding, using an alternative medicine, or closely monitoring the infant for excessive sleepiness, poor feeding, or other unusual symptoms.

Pregabalin is primarily eliminated through the kidneys. In patients with reduced kidney function, the drug can accumulate and increase the risk of side effects if the dose is not adjusted. Individuals with known kidney disease, those on dialysis, or elderly patients (who more commonly have reduced renal function) should inform their doctor before starting Maxmala 75. The prescriber will determine if the medicine is appropriate and, if so, select an individualized dosing regimen and monitoring plan.

Yes. Maxmala 75 can cause dizziness, drowsiness, blurred vision, and impaired concentration or coordination, particularly when starting treatment or after dose changes. These effects can significantly reduce the ability to drive, operate machinery, or perform tasks that require alertness. Patients should not drive or use heavy machinery until they know how the medicine affects them and should follow their doctor’s advice and local regulations regarding driving while on this medication.